At this time, the firm appears to be fairly valued. Elevance Health shows a prevailing Real Value of $337.24 per share. The current price of the firm is $340.6. Our model computes the value of Elevance Health from reviewing the firm fundamentals such as Current Valuation of 98.52 B, shares outstanding of 222.24 M, and Profit Margin of 0.03 % as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Elevance Health's valuation include:
Price Book
1.7151
Enterprise Value
98.5 B
Price Sales
0.3852
Forward PE
12.3153
Trailing PE
13.4412
Fairly Valued
Today
340.60
Please note that Elevance Health's price fluctuation is very steady at this time. Calculation of the real value of Elevance Health is based on 3 months time horizon. Increasing Elevance Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Elevance stock is determined by what a typical buyer is willing to pay for full or partial control of Elevance Health. Since Elevance Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Elevance Stock. However, Elevance Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical
Market 340.6
Real 337.24
Target 387.85
Hype 340.19
Naive 324.53
The intrinsic value of Elevance Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Elevance Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Elevance Health helps investors to forecast how Elevance stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Elevance Health more accurately as focusing exclusively on Elevance Health's fundamentals will not take into account other important factors:
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Elevance Health's intrinsic value based on its ongoing forecasts of Elevance Health's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Elevance Health's closest peers.
Elevance Health Cash
9.97 Billion
Elevance Revenue by Product
Elevance Health Total Value Analysis
Elevance Health is currently expected to have company total value of 98.52 B with market capitalization of 76.7 B, debt of 32.05 B, and cash on hands of 8.29 B. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Elevance Health fundamentals before making security assessment based on enterprise value of the company
About 92.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.72. Some equities with similar Price to Book (P/B) outperform the market in the long run. Elevance Health has Price/Earnings To Growth (PEG) ratio of 1.27. The entity recorded earning per share (EPS) of 25.34. The firm last dividend was issued on the 10th of March 2026. Elevance Health had 2:1 split on the 1st of June 2005. Elevance Health may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Elevance Health has an asset utilization ratio of 163.54 percent. This indicates that the Company is making $1.64 for each dollar of assets. An increasing asset utilization means that Elevance Health is more efficient with each dollar of assets it utilizes for everyday operations.
Dot-com Bubble
Housing Crash
Credit Downgrade
Yuan Drop
Covid
Interest Hikes
Elevance Health Profitability Analysis
Considering the key profitability indicators obtained from Elevance Health's historical financial statements, Elevance Health's profitability may be sliding down. It has an above-average probability of reporting lower numbers next quarter. Profitability indicators assess Elevance Health's ability to earn profits and add value for shareholders.
Net Income
First Reported
2000-03-31
Previous Quarter
1.2 B
Current Value
547 M
Quarterly Volatility
578.4 M
Dot-com Bubble
Housing Crash
Credit Downgrade
Yuan Drop
Covid
Interest Hikes
At this time, Elevance Health's Operating Profit Margin is fairly stable compared to the past year. Net Profit Margin is likely to climb to 0.03 in 2026, whereas Gross Profit is likely to drop slightly above 80.3 B in 2026.
For Elevance Health profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Elevance Health to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Elevance Health utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Elevance Health's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Elevance Health over time as well as its relative position and ranking within its peers.
Elevance Health Earnings per Share Projection vs Actual
The next projected EPS of Elevance Health is estimated to be 10.54 with future projections ranging from a low of 6.5344 to a high of 11.34. Elevance Health's most recent 12-month trailing earnings per share (EPS TTM) is at 25.34. Please be aware that the consensus of earnings estimates for Elevance Health is based on EPS before non-recurring items and includes expenses related to employee stock options.
Housing Crash
Credit Downgrade
Yuan Drop
Covid
Interest Hikes
Elevance Health is projected to generate 10.54 in earnings per share on the 31st of March 2026. Elevance Health earnings estimates show analyst consensus about projected Elevance Health EPS (Earning Per Share). It derives the highest and the lowest estimates based on Elevance Health's historical volatility. Many public companies, such as Elevance Health, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.
Elevance Health Earnings Estimation Breakdown
The calculation of Elevance Health's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Elevance Health is estimated to be 10.54 with the future projection ranging from a low of 6.5344 to a high of 11.34. Please be aware that this consensus of annual earnings estimates for Elevance Health is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
3.33
6.53
Lowest
Expected EPS
10.54
11.34
Highest
Elevance Health Earnings Projection Consensus
Suppose the current estimates of Elevance Health's value are higher than the current market price of the Elevance Health stock. In this case, investors may conclude that Elevance Health is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Elevance Health's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of Analysts
Historical Accuracy
Last Reported EPS
Estimated EPS for 31st of March 2026
Current EPS (TTM)
22
95.39%
3.33
10.54
25.34
Elevance Health Ownership Allocation
Elevance Health holds a total of 222.24 Million outstanding shares. The majority of Elevance Health outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Elevance Health to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Elevance Health. Please pay attention to any change in the institutional holdings of Elevance Health as this could imply that something significant has changed or is about to change at the company. Please note that on January 16, 2026, Senator Markwayne Mullin of US Senate acquired $15k to $50k worth of Elevance Health's common stock.
Elevance Health Profitability Analysis
The company reported the last year's revenue of 198.69 B. Total Income to common stockholders was 5.66 B with profit before taxes, overhead, and interest of 50.9 B.
Elevance Health Past Distributions to stockholders
Our relative valuation model uses a comparative analysis of Elevance Health. We calculate exposure to Elevance Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Elevance Health's related companies.
Elevance Health's stock price is the clearest measure of market expectations about its performance. Without stock valuation, investors cannot independently discern whether Elevance Health's value is low or high relative to the company's performance and growth projections. Determining the market value of Elevance Health can be done in different ways, such as multiplying its stock price by its outstanding shares.
A single share of Elevance Health represents a small ownership stake in the entity. As a stockholder of Elevance, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
There are various types of dividends Elevance Health can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Elevance shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Elevance Health directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Elevance pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Elevance Health by the value of the dividends paid out.
Elevance Health Growth Indicators
Investing in growth stocks can be very risky. If the company such as Elevance Health does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding
221.8 M
Quarterly Earnings Growth Y O Y
0.363
Forward Price Earnings
12.3153
Elevance Health Current Valuation Indicators
Elevance Health's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Elevance Health's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Elevance Health, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Elevance Health's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Elevance Health's worth.
Additional Tools for Elevance Stock Analysis
When running Elevance Health's price analysis, check to measure Elevance Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevance Health is operating at the current time. Most of Elevance Health's value examination focuses on studying past and present price action to predict the probability of Elevance Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevance Health's price. Additionally, you may evaluate how the addition of Elevance Health to your portfolios can decrease your overall portfolio volatility.